Norges Bank
ALT icon

Norges Bank’s Altimmune ALT Stock Holding History

Norges Bank’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-189,600
Closed -$2.22M – 2092
2022
Q2 		$2.22M Hold
189,600
– – ﹤0.01% 1889
2022
Q1 		$1.15M Hold
189,600
– – ﹤0.01% 2036
2021
Q4 		$1.74M Buy
189,600
+122,000
+180% +$1.3M ﹤0.01% 2049
2021
Q3 		$765K Sell
67,600
-262,200
-80% -$3.19M ﹤0.01% 2168
2021
Q2 		$3.25M Buy
+329,800
New +$4.51M ﹤0.01% 1954

Other funds holding ALT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank's ALT Position: Q3 2022 in Review

Norges Bank sold out of Altimmune (ALT) in Q3 2022, closing a stake of 189,600 shares — an estimated $2.22M sold.

Norges Bank first reported a position in ALT in Q2 2021 and held it in 5 quarters. The position peaked at $3.25M in Q2 2021. 122 funds tracked by Wall St. Rank hold ALT as of Q3 2022.

  • Norges Bank reported no remaining Altimmune position as of Q3 2022 after selling out during the quarter.
  • Norges Bank sold 189,600 Altimmune shares in Q3 2022, an estimated $2.22M.
  • Norges Bank first reported a position in Altimmune in Q2 2021 and held it in 5 quarters.
  • Norges Bank's Altimmune position peaked at $3.25M in Q2 2021.
  • 122 funds tracked by Wall St. Rank held Altimmune as of Q3 2022.

Based on Norges Bank's 13F filing for Q3 2022, filed 14 Nov 2022.